Nektar Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

넥타 테라퓨틱스NASDAQ:NKTR · Nasdaq · Healthcare

$43.58-7.26%

2026-10-02 close

Nektar Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $98M. 2024 operating profit was −$105M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy